CAR T Cell therapy - first patient treated with FT596 "off the shelf" product - longer term Mantle Cell data promising.

Classification of Non-Hodgkin Lymphomas is necessary to determine treatment.

HDC and ASCT is the standard of care for treatment of several types of lymphomas in a variety of situations.

Tazverik is a novel precision cancer medicine that targets the EZH2 cancer causing mutation in follicular lymphoma.

The Selective Inhibitor of Nuclear Export (SINE) Selinexor being developed as new treatment for lymphoma.

Research demonstrates that some patients with NHL can be treated with 4 instead of 6 cycles of R-CHOP.

Ten things every patient with lymphoma should consider in order to get the best possible treatment

Hepatitis C Infection Increases Risk of Lymphoma and Multiple Myeloma